Bioequivalence studies of reformulated pharmaceuticals newly off patent

References

1. Chen, ML, Shah V, Patnaik R, Adams W, Hussain A, Conner D, et al. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res. 2001; 18: 1645-50.10.1023/A:1013319408893
Open DOI Search in Google Scholar Back to article
2. Raw AS, Furness MS, Gill DS, Adams RC, Holcombe FO, Yu LX. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Adv Drug Deliv Rev. 2004; 56:397-414.10.1016/j.addr.2003.10.01114962589
Search in Google Scholar Back to article
3. WHO Tech Rep Ser. Additional guidelines for organizations performing in vivo bioequivalence studies. Geneva 2006.
Search in Google Scholar Back to article
4. Jullangkoon, M, Jarurathanasirikul S, Ainlang N. Bioequivalence study of cefepime intramuscular injection in healthy volunteers. Asian Biomed. 2014; 8: 237-4010.5372/1905-7415.0802.284
Search in Google Scholar Back to article